Coppell Advisory Solutions LLC purchased a new stake in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) during the 1st quarter, Holdings Channel.com reports. The institutional investor purchased 4,862 shares of the company’s stock, valued at approximately $170,000.
Other large investors have also modified their holdings of the company. Compass Wealth Management LLC raised its holdings in shares of Option Care Health by 8.9% during the first quarter. Compass Wealth Management LLC now owns 166,078 shares of the company’s stock valued at $5,804,000 after acquiring an additional 13,600 shares during the period. Bessemer Group Inc. grew its position in Option Care Health by 62.3% during the 1st quarter. Bessemer Group Inc. now owns 1,560 shares of the company’s stock worth $54,000 after purchasing an additional 599 shares in the last quarter. Principal Financial Group Inc. raised its stake in Option Care Health by 1.4% during the 1st quarter. Principal Financial Group Inc. now owns 485,871 shares of the company’s stock valued at $16,981,000 after purchasing an additional 6,616 shares during the period. Wealth Enhancement Advisory Services LLC raised its stake in Option Care Health by 25.7% during the 1st quarter. Wealth Enhancement Advisory Services LLC now owns 8,274 shares of the company’s stock valued at $289,000 after purchasing an additional 1,691 shares during the period. Finally, GAMMA Investing LLC lifted its holdings in shares of Option Care Health by 307.1% in the first quarter. GAMMA Investing LLC now owns 3,192 shares of the company’s stock valued at $112,000 after purchasing an additional 2,408 shares in the last quarter. 98.05% of the stock is owned by institutional investors.
Option Care Health Stock Performance
Shares of OPCH stock opened at $29.25 on Wednesday. Option Care Health, Inc. has a fifty-two week low of $21.39 and a fifty-two week high of $35.53. The stock’s 50-day moving average is $29.18 and its two-hundred day moving average is $31.51. The company has a debt-to-equity ratio of 0.81, a current ratio of 1.52 and a quick ratio of 1.00. The firm has a market cap of $4.75 billion, a P/E ratio of 23.40, a PEG ratio of 1.80 and a beta of 0.83.
Wall Street Analyst Weigh In
Several research analysts recently weighed in on OPCH shares. Citigroup reissued an “outperform” rating on shares of Option Care Health in a research report on Thursday, July 31st. Barrington Research reaffirmed an “outperform” rating and set a $38.00 target price on shares of Option Care Health in a research note on Thursday, July 10th. Finally, JMP Securities increased their price target on shares of Option Care Health from $36.00 to $38.00 and gave the stock a “market outperform” rating in a research report on Thursday, July 31st. Eight analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. Based on data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $35.75.
Get Our Latest Stock Analysis on Option Care Health
Insiders Place Their Bets
In related news, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of Option Care Health stock in a transaction on Wednesday, August 20th. The stock was purchased at an average cost of $27.15 per share, with a total value of $977,400.00. Following the acquisition, the director directly owned 375,390 shares in the company, valued at approximately $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, Director Timothy P. Sullivan bought 20,000 shares of Option Care Health stock in a transaction that occurred on Thursday, August 21st. The stock was bought at an average price of $27.51 per share, with a total value of $550,200.00. Following the purchase, the director owned 49,229 shares of the company’s stock, valued at $1,354,289.79. This trade represents a 68.43% increase in their position. The disclosure for this purchase can be found here. 0.64% of the stock is owned by insiders.
Option Care Health Profile
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Stories
- Five stocks we like better than Option Care Health
- What is diluted earnings per share (Diluted EPS)?
- Is Qualcomm Tesla’s Next Rival in Autonomous Driving?
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- 3 Under-the-Radar Biotechs Under $5 That Could Soar 200%
- Where Do I Find 52-Week Highs and Lows?
- The Quiet Before the Catalyst: Vertical Aerospace’s Next Move
Want to see what other hedge funds are holding OPCH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Option Care Health, Inc. (NASDAQ:OPCH – Free Report).
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.